ABUS - Arbutus Biopharma Corporation

-

$undefined

N/A

(N/A)

Arbutus Biopharma Corporation NASDAQ:ABUS Arbutus Biopharma Corporation is a biopharmaceutical company primarily dedicated to discovering, developing and commercializing a cure for people with chronic hepatitis B virus (HBV) infection. The Company is advancing multiple drug product candidates that may be combined into a potentially curative regimen for chronic HBV infection. Arbutus has also initiated a drug discovery and development effort for treating coronaviruses (including COVID-19).

Location: 701 Veterans Circle, Pennsylvania, 18974, US | Website: arbutusbio.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

553.6M

Cash

127.8M

Avg Qtr Burn

-17.96M

Short % of Float

4.27%

Insider Ownership

22.22%

Institutional Own.

53.90%

Qtr Updated

09/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Phase 2a

Data readout

Phase 2a

Data readout

AB-101 Details
Hepatitis B

Phase 1

Data readout

Failed

Discontinued

Failed

Discontinued

Failed

Discontinued